CAPTRUST Financial Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-485	Closed	-$3K	–	4292
2022 Q2	$3K	Buy	485 +109	+29%	+$893	﹤0.01%	4371
2022 Q1	$6K	Buy	376 +190	+102%	+$2.54K	﹤0.01%	4100
2021 Q4	$3K	Sell	186 -50	-21%	-$1.2K	﹤0.01%	4324
2021 Q3	$8K	Hold	236	–	–	﹤0.01%	3759
2021 Q2	$10K	Buy	236 +18	+8%	+$739	﹤0.01%	3560
2021 Q1	$11K	Buy	218 +65	+42%	+$3.4K	﹤0.01%	3401
2020 Q4	$5K	Hold	153	–	–	﹤0.01%	2879
2020 Q3	$2K	Hold	153	–	–	﹤0.01%	2827
2020 Q2	$2K	Buy	+153	New	+$1.99K	﹤0.01%	2642

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIA

Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CAPTRUST Financial Advisors's DMTK Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 485 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in DMTK in Q2 2020 and held it in 9 quarters. The position peaked at $11K in Q1 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 485 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $3K.
CAPTRUST Financial Advisors first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
CAPTRUST Financial Advisors's DermTech, Inc. Common Stock position peaked at $11K in Q1 2021.
127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.